Trial Profile
Phase I trial of GLG-302 in patients with triple negative breast cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 04 Mar 2016
Price :
$35
*
At a glance
- Drugs GLG 302 (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- Sponsors GLG Pharma
- 04 Mar 2016 New trial record